These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
219 related items for PubMed ID: 17554495
21. Correlation between 99mTc-(V)-DMSA uptake and constitutive level of phosphorylated focal adhesion kinase in an in vitro model of cancer cell lines. Denoyer D, Perek N, Le Jeune N, Cornillon J, Dubois F. Eur J Nucl Med Mol Imaging; 2005 Jul; 32(7):820-7. PubMed ID: 15785954 [Abstract] [Full Text] [Related]
22. Usefulness of (99m)Tc(V)-dimercaptosuccinic acid scintigraphy in the assessment of response to external radiation therapy in soft tissue sarcoma in Giant Snauzer dog. Chaudhari PR, Mathe D, Balogh L, Andocs G, Janoki GA. Nucl Med Rev Cent East Eur; 2005 Jul; 8(2):150-2. PubMed ID: 16437404 [Abstract] [Full Text] [Related]
23. Comparison between contrast-enhanced magnetic resonance imaging and technetium 99m glucohepatonic acid single photon emission computed tomography with histopathologic correlation in gliomas. Kumar RA, Khandelwal N, Sodhi KS, Pathak A, Mittal BR, Radotra BD, Suri S. J Comput Assist Tomogr; 2006 Jul; 30(5):723-33. PubMed ID: 16954918 [Abstract] [Full Text] [Related]
24. The value of 99mTc-tetrofosmin brain SPECT in predicting survival in patients with glioblastoma multiforme. Alexiou GA, Tsiouris S, Kyritsis AP, Fotakopoulos G, Goussia A, Voulgaris S, Fotopoulos AD. J Nucl Med; 2010 Dec; 51(12):1923-6. PubMed ID: 21078797 [Abstract] [Full Text] [Related]
25. Imaging in situ breast carcinoma (with or without an invasive component) with technetium-99m pentavalent dimercaptosuccinic acid and technetium-99m 2-methoxy isobutyl isonitrile scintimammography. Papantoniou V, Tsiouris S, Mainta E, Valotassiou V, Souvatzoglou M, Sotiropoulou M, Nakopoulou L, Lazaris D, Louvrou A, Melissinou M, Tzannetaki A, Pirmettis I, Koutsikos J, Zerva C. Breast Cancer Res; 2005 Dec; 7(1):R33-45. PubMed ID: 15642168 [Abstract] [Full Text] [Related]
28. Imaging of recurrent brain tumors with trivalent (99m)Tc-dimercaptosuccinic acid - initial results. Barai S, Bandopadhayaya G, Julka P, Malhotra A, Naik K, Haloi A, Seith A, Halanaik D. Hell J Nucl Med; 2004 Jan; 7(1):44-7. PubMed ID: 16868641 [Abstract] [Full Text] [Related]
29. Scintimammographic findings of phyllodes tumor of the breast in a double-phase study with Tc-99m (V)DMSA and Tc-99m MIBI: a case report. Papantoniou V, Koutsikos J, Sotiropoulou M, Mainta E, Lazaris D, Tsiouris S, Zerva C. Jpn J Clin Oncol; 2004 Jul; 34(7):429-31. PubMed ID: 15342672 [Abstract] [Full Text] [Related]
30. Posttherapy technetium-99m pentavalent dimercaptosuccinic acid brain single-photon emission computed tomography/computed tomography: diagnostic and prognostic values in patients with glioma. Mohamadien NRA, Diab WA, Abd El-Ghani WMA, Abdelhafez YG. Nucl Med Commun; 2022 Dec 01; 43(12):1195-1203. PubMed ID: 36345764 [Abstract] [Full Text] [Related]
31. Tc-99m pentavalent DMSA scintigraphy in myelofibrosis detection. Koutsikos JT, Velidaki A, Athanasoulis T. Clin Nucl Med; 2006 Dec 01; 31(12):806-7. PubMed ID: 17117079 [Abstract] [Full Text] [Related]
32. 99Tc(m)(V)DMSA scintigraphy in skeletal metastases and superscans arising from various malignancies: diagnosis, treatment monitoring and therapeutic implications. Basu S, Nair N, Awasare S, Tiwari BP, Asopa R, Nair C. Br J Radiol; 2004 Apr 01; 77(916):347-61. PubMed ID: 15107330 [Abstract] [Full Text] [Related]
33. Increased breast density correlates with the proliferation-seeking radiotracer (99m)Tc(V)-DMSA uptake in florid epithelial hyperplasia and in mixed ductal carcinoma in situ with invasive ductal carcinoma but not in pure invasive ductal carcinoma or in mild epithelial hyperplasia. Papantoniou V, Valsamaki P, Sotiropoulou E, Tsaroucha A, Tsiouris S, Sotiropoulou M, Marinopoulos S, Kounadi E, Karianos T, Fothiadaki A, Archontaki A, Syrgiannis K, Ptohis N, Makris N, Limouris G, Antsaklis A. Mol Imaging; 2011 Oct 01; 10(5):370-6. PubMed ID: 21521552 [Abstract] [Full Text] [Related]
34. Combined use of 99mTc-sestamibi and 99mTc-V-DMSA in the assessment of chemotherapy effectiveness in patients with multiple myeloma. Koutsikos J, Athanasoulis T, Anagnostopoulos A, Velidaki A, Passadi M, Dimopoulos MA, Zerva C. J Nucl Med; 2005 Jun 01; 46(6):978-82. PubMed ID: 15937309 [Abstract] [Full Text] [Related]
35. Reverse of the differential uptake intensity of Tc-99m MIBI and Tc-99m V-DMSA by multiple myeloma lesions in response to therapy. Athanasoulis T, Koutsikos J, Moulopoulos LA, Tsiouris S, Dimopoulos MA, Zerva C. Clin Nucl Med; 2003 Aug 01; 28(8):631-5. PubMed ID: 12897645 [Abstract] [Full Text] [Related]
36. The multidrug resistance of in vitro tumor cell lines derived from human breast carcinoma MCF-7 does not influence pentavalent technetium-99m-dimercaptosuccinic Acid uptake. Denoyer D, Perek N, Le Jeune N, Frère D, Dubois F. Cancer Biother Radiopharm; 2003 Oct 01; 18(5):791-801. PubMed ID: 14629827 [Abstract] [Full Text] [Related]